AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
Log in

NASDAQ:CYCNCyclerion Therapeutics Stock Price, Forecast & News

$5.87
+0.07 (+1.21 %)
(As of 07/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.73
Now: $5.87
$6.00
50-Day Range
$3.60
MA: $4.82
$7.14
52-Week Range
$1.69
Now: $5.87
$14.83
Volume118,126 shs
Average Volume413,447 shs
Market Capitalization$162.92 million
P/E RatioN/A
Dividend YieldN/A
Beta1.36
There is no company description available for Cyclerion Therapeutics Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYCN
CUSIPN/A
CIKN/A
Phone857-327-8778

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.51 million
Book Value$3.56 per share

Profitability

Net Income$-123,010,000.00
Net Margins-1,917.30%

Miscellaneous

EmployeesN/A
Market Cap$162.92 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive CYCN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter.

Cyclerion Therapeutics (NASDAQ:CYCN) Frequently Asked Questions

How has Cyclerion Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Cyclerion Therapeutics' stock was trading at $2.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CYCN shares have increased by 102.4% and is now trading at $5.87. View which stocks have been most impacted by Coronavirus.

When is Cyclerion Therapeutics' next earnings date?

Cyclerion Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Cyclerion Therapeutics.

How were Cyclerion Therapeutics' earnings last quarter?

Cyclerion Therapeutics Inc (NASDAQ:CYCN) announced its quarterly earnings data on Monday, May, 4th. The company reported ($0.73) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.87) by $0.14. The firm earned $1.01 million during the quarter. Cyclerion Therapeutics had a negative net margin of 1,917.30% and a negative return on equity of 96.31%. View Cyclerion Therapeutics' earnings history.

Has Cyclerion Therapeutics been receiving favorable news coverage?

News stories about CYCN stock have been trending very negative this week, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cyclerion Therapeutics earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Cyclerion Therapeutics.

Are investors shorting Cyclerion Therapeutics?

Cyclerion Therapeutics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 990,200 shares, a decrease of 15.4% from the May 31st total of 1,170,000 shares. Based on an average daily trading volume, of 241,200 shares, the days-to-cover ratio is currently 4.1 days. Currently, 4.3% of the shares of the company are sold short. View Cyclerion Therapeutics' Current Options Chain.

Who are some of Cyclerion Therapeutics' key competitors?

What other stocks do shareholders of Cyclerion Therapeutics own?

What is Cyclerion Therapeutics' stock symbol?

Cyclerion Therapeutics trades on the NASDAQ under the ticker symbol "CYCN."

How do I buy shares of Cyclerion Therapeutics?

Shares of CYCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cyclerion Therapeutics' stock price today?

One share of CYCN stock can currently be purchased for approximately $5.87.

How big of a company is Cyclerion Therapeutics?

Cyclerion Therapeutics has a market capitalization of $162.92 million and generates $4.51 million in revenue each year.

What is Cyclerion Therapeutics' official website?

The official website for Cyclerion Therapeutics is www.cyclerion.com.

How can I contact Cyclerion Therapeutics?

Cyclerion Therapeutics' mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The company can be reached via phone at 857-327-8778 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.